532-32-1

Applied Filters:

Keyword:'532-32-1'

Showing 1-5 of 5 results for "532-32-1" within Papers

Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.

Michie Hisada et al.

The Journal of infectious diseases, 185(9), 1351-1354 (2002-05-10)

Polymorphisms of some chemokine receptor genes and their ligands are associated with susceptibility and progression of human immunodeficiency virus infection. This study assessed whether these variants are also responsible for susceptibility to infection with human T lymphotropic virus (HTLV) type

Biodegradation studies of N4-acetylsulfapyridine and N4-acetylsulfamethazine in environmental water by applying mass spectrometry techniques.

María Jesús García-Galán et al.

Analytical and bioanalytical chemistry, 402(9), 2885-2896 (2012-02-22)

This work evaluates the biodegradation of N(4)-acetylsulfapyridine (AcSPY) and N(4)-acetylsulfamethazine (AcSMZ), metabolites of two of the most commonly used sulfonamides (SAs) in human and veterinary medicine, respectively. Aerobic transformation in effluent wastewater was simulated using aerated fixed-bed bioreactors. No visible

Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.

Surtaj H Iram et al.

The Journal of biological chemistry, 286(9), 7202-7213 (2010-12-24)

Multidrug resistance protein 1 (MRP1) is an ATP-binding cassette transporter that effluxes drugs and organic anions across the plasma membrane. The 17 transmembrane helices of MRP1 are linked by extracellular and cytoplasmic loops (CLs), but their role in coupling the

Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction.

T Ebert et al.

Nutrition, metabolism, and cardiovascular diseases : NMCD, 24(9), 1027-1034 (2014-05-13)

The adipokine adipocyte fatty acid binding protein (AFABP) is positively associated with the development of the metabolic syndrome, diabetes mellitus, and cardiovascular disease. We hypothesized that AFABP also increases with deteriorating renal function. Serum AFABP levels were quantified by enzyme

Bioequivalence study with two different oral formulations of methocarbamol in healthy subjects. A mono-centre, comparative, randomized, open-label, single-dose, 2-way crossover study.

Ronald Schlegelmilch et al.

Arzneimittel-Forschung, 59(5), 238-242 (2009-06-23)

The objective of this study was to compare the pharmacokinetic profile of a new oral methocarbamol (CAS 532-03-6) formulation (DoloVisano Methocarbamol 750 mg Tabletten) to that of a registered reference product and to demonstrate the bioequivalence of the formulations with

Page 1 of 1